Oruka Therapeutics Inc. (ORKA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
13.94
0.07 (0.50%)
At close: Jan 15, 2025, 3:59 PM
13.97
0.22%
After-hours Jan 15, 2025, 04:00 PM EST
undefined% (undefined)
Bid | 11.01 |
Market Cap | 487.88M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | n/a |
PE Ratio (ttm) | n/a |
Forward PE | n/a |
Analyst | Buy |
Ask | 16 |
Volume | 400,760 |
Avg. Volume (20D) | 259,727 |
Open | 14.24 |
Previous Close | 13.87 |
Day's Range | 13.75 - 14.40 |
52-Week Range | 13.17 - 53.88 |
Beta | undefined |
About ORKA
A detailed description of the company is not yet available....
Analyst Forecast
According to 7 analyst ratings, the average rating for ORKA stock is "Buy." The 12-month stock price forecast is $44, which is an increase of 215.64% from the latest price.
Buy 85.71%
Hold 0.00%
Sell 0.00%
2 months ago ·
Source
-6.43%
Oruka Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
4 months ago ·
Source
+9.76%
Oruka Therapeutics shares are trading higher after Wedbush initiated coverage on the stock with an Outperform rating and announced a $40 price target.